NCT02448537 2021-03-03A Phase II Multi-Strata Study of PM01183 as a Single Agent or in Combination With Conventional Chemotherapy in Metastatic and/or Unresectable SarcomasMassachusetts General HospitalPhase 2 Completed42 enrolled 11 charts